TITLE

Review: Drug-eluting stents are more effective than bare-metal stents for reducing acute MI at 6 to 12 months after implantation: COMMENTARY

AUTHOR(S)
Massel, David; Kumar, Sridhar
PUB. DATE
July 2007
SOURCE
ACP Journal Club;Jul/Aug2007, Vol. 147 Issue 1, p13
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The authors reflect on a study, conducted by R. Moreno and colleagues, which compares the effectiveness of drug-eluting stents (DESs) and bare-metal stents (BMSs) for reducing risk for acute myocardial infarction (MI) in patients undergoing stent implantation. They view that restenosis risk should be curtailed by DESs. However, they opine that in late stent thrombosis DESs seems to present a higher risk which can be reduced by prolonged use of aspirin and clopidogrel.
ACCESSION #
25913650

 

Related Articles

  • NSAID use in patients with prior Ml.  // Primary Care Reports;Jul2011 Pharmacology Watch, p1 

    The article discusses a study by researchers from Denmark concerning the risk of nonsteroidal anti-inflammatory drug (NSAID) use in patients with prior myocardial infarction (MI). The study suggested that the risk of death and recurrent MI increases with the brief use of NSAID. Diclofenac has...

  • Nonaspirin NSAIDs do not significantly alter risk of acute MI.  // Reactions Weekly;7/17/2004, Issue 1010, p3 

    Discusses research being done on nonsteroidal antiinflammatory drugs (NSAID) and the risk of myocardial infarction (MI). Reference to a study by L. A. Garcia Rodriguez et al, published in the June 2004 issue of "Circulation"; Assessment of the association of the drugs with reduction in MI;...

  • NSAIDs may increase risk of first MI. Ford, Steve // Practice Nurse;8/18/2006, Vol. 32 Issue 3, p45 

    The article discusses research being done on the role of nonsteroidal anti-inflammatory drugs (NSAID) in increasing the risk of fist myocardial infarction (MI). It references a study published in a 2006 issue of European Heart Journal. Researchers found current use of NSAID in 2,979 cases and...

  • Posterior cerebral artery dissecting aneurysm: another cause of perimesencephalic pattern of subarachnoid haemorrhage. Lobo, Patrícia Pita; Campos, Jorge; Neto, Lia; Canhão, Patrícia // Journal of Neurology, Neurosurgery & Psychiatry;May2011, Vol. 82 Issue 5, p584 

    The article discusses the case of a patient with a perimesencephalic pattern of subarachnoid hemorrhage (SAH) caused by rupture of dissecting posterior cerebral artery (PCA) aneurysm. The case involved a 62-year old man who experienced severe headache, nausea, and vomiting and had a medical...

  • What to Know About Aspirin Therapy.  // National Women's Health Report;Feb2005, Vol. 27 Issue 1, p5 

    Provides information about aspirin therapy in the U.S. Connection between aspirin and heart attack prevention; Risk of gastrointestinal bleeding in taking aspirin; Recommendation for people at high risk for heart attack or stroke to take aspirin.

  • Global Safety of Coxibs and NSAIDs. Pham, K.; Hirschberg, R. // Current Topics in Medicinal Chemistry;Jun2005, Vol. 5 Issue 5, p465 

    Non-steroidal anti-inflammatory drugs (NSAIDs) and selective cyclooxygenase-2 inhibitors (Coxibs) are commonly used for minor pain treatment and chronically in the management of rheumatoid arthritis and osteoarthritis. Three areas of safety concerns are shared by both groups of drugs:...

  • A Multi-Country Economic Evaluation of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease. Lamotte, Mark; Annemans, Lieven; Evers, Thomas; Kubin, Maria // PharmacoEconomics;2006, Vol. 24 Issue 2, p155 

    Background: Low-dose aspirin (acetylsalicylic acid) is standard care in patients with a history of cardiovascular disease (CVD). The use of low-dose aspirin in primary prevention is not yet fully established, although meta-analyses and US and European guidelines support its use in people at...

  • Aspirin for the next generation. Henderson, Nick; Smith, Tom // Ecancermedicalscience;2013, Vol. 7, p1 

    First used as an analgesic and antipyretic, investigations into aspirin's anti-inflammatory effects led to its establishment in 1974 as a drug that altered the activity of platelets to influence the course and incidence of myocardial infarction and cerebrovascular disease. It became the standard...

  • NSAID use in patients with prior MI. Elliott, William T. // Neurology Alert;Jul2011 Clinical Briefs in Primary, p1 

    The article discusses a study which suggested that the brief use of nonsteroidal anti-inflammatory drugs (NSAIDS) in patients who had a myocardial infarction (MI) increases the risk for death and the recurrence of the disease. The correlation between the risk of death or recurrent MI and the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics